We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$2.67B
AUM Growth
+$265M
Cap. Flow
+$453M
Cap. Flow %
16.99%
Top 10 Hldgs %
13.61%
Holding
878
New
229
Increased
191
Reduced
239
Closed
127

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.6M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$19.6M
3
HAS icon
Hasbro
HAS
+$12.8M
4
BKU icon
Bankunited
BKU
+$10.4M
5
DLX icon
Deluxe
DLX
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 17.28%
2 Healthcare 13.75%
3 Technology 11.2%
4 Industrials 9.84%
5 Consumer Discretionary 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFX icon
376
Equifax
EFX
$20.3B
$1.01M 0.04%
10,440
BRKL
377
DELISTED
Brookline Bancorp
BRKL
$1.01M 0.04%
99,254
+500
+0.5% +$5.44K
XRM
378
DELISTED
Xerium Technologies Inc (new)
XRM
$998K 0.04%
76,874
-1,231
-2% -$18.3K
MKC icon
379
McCormick & Company Non-Voting
MKC
$13.4B
$987K 0.04%
+24,014
New +$976K
AIN icon
380
Albany International
AIN
$2.14B
$985K 0.04%
+34,412
New +$1.17M
USMV icon
381
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$981K 0.04%
24,774
-5,189
-17% -$212K
VCSH icon
382
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$978K 0.04%
12,271
PFC
383
DELISTED
Premier Financial Corp. Common Stock
PFC
$964K 0.04%
52,720
+9,556
+22% +$177K
DGX icon
384
Quest Diagnostics
DGX
$25.1B
$955K 0.04%
+15,534
New +$1.09M
NVO
385
Novo Nordisk
NVO
$216B
$940K 0.04%
34,650
+500
+1% +$14.2K
MBFI
386
DELISTED
MB Financial Corp
MBFI
$939K 0.04%
+28,769
New +$960K
BHI
387
DELISTED
Baker Hughes
BHI
$929K 0.03%
17,853
-3,242
-15% -$181K
MANH icon
388
Manhattan Associates
MANH
$8.97B
$922K 0.03%
14,796
-6,575
-31% -$410K
TGNA
389
DELISTED
TEGNA Inc
TGNA
$921K 0.03%
64,281
-87,158
-58% -$1.48M
ADP icon
390
Automatic Data Processing
ADP
$100B
$920K 0.03%
11,451
PRI icon
391
Primerica
PRI
$9.81B
$919K 0.03%
+20,399
New +$893K
USB icon
392
US Bancorp
USB
$99.6B
$911K 0.03%
22,212
+11
+0% +$476
DOV icon
393
Dover
DOV
$27.2B
$910K 0.03%
19,708
-1,695
-8% -$85.8K
WEC icon
394
WEC Energy
WEC
$37.7B
$909K 0.03%
17,416
VNQ icon
395
Vanguard Real Estate ETF
VNQ
$39.9B
$903K 0.03%
11,953
-1,876
-14% -$144K
KEP icon
396
Korea Electric Power
KEP
$15.5B
$900K 0.03%
+43,930
New +$914K
VCIT icon
397
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$899K 0.03%
10,529
-200
-2% -$17K
FUN icon
398
Cedar Fair
FUN
$1.78B
$894K 0.03%
16,993
+538
+3% +$29.2K
IP icon
399
International Paper
IP
$22.3B
$892K 0.03%
24,921
-146,392
-85% -$6.2M
LXFT
400
DELISTED
Luxoft Holding, Inc.
LXFT
$888K 0.03%
14,025
-820
-6% -$51K

Similar funds

Boston Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Advisors held 878 positions worth $2.67B, up 11% from $2.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Advisors deployed $453M of net new capital in Q3 2015, opening 229 new positions and adding to 191 existing holdings. Its largest new stake was Alphabet (Google) Class A: 671,860 shares worth $21.4M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $23.3M trimmed.

  • Boston Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 671,860 shares worth $21.4M.
  • Boston Advisors added most to iShares Russell 2000 ETF in Q3 2015, an estimated $19.6M increase.
  • Boston Advisors's biggest Q3 2015 reduction was Bristol-Myers Squibb, cutting an estimated $23.3M.
  • Boston Advisors fully exited Thomson Reuters in Q3 2015, selling an estimated $13.1M.
  • Boston Advisors's ten largest holdings make up 14% of its $2.67B portfolio in Q3 2015.
  • Boston Advisors opened 229 new positions and closed 127 in Q3 2015.
  • Boston Advisors's portfolio value rose 11% quarter-over-quarter to $2.67B.

Based on Boston Advisors's 13F filing for Q3 2015, filed 28 Oct 2015.